 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Can Fite BioPharma stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:CANF! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Can Fite BioPharma stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. The company’s lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical trial for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is completed Phase II clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase II trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. Can-Fite BioPharma Ltd. has collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel.
Average volume
739,167 shs
MARKET CAP
$35.71 million
Stock exchange
NYSEAMERICAN
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
AMEX:CANF
|
Pharmaceutical preparations
|
Medical
|
11,364 shs
|
Below is a quick guide on how to buy AMEX:CANF stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Can Fite BioPharma shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Can Fite BioPharma – Search for “”AMEX:CANF”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Can Fite BioPharma stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
1 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Can-Fite BioPharma in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should “buy” Can-Fite BioPharma stock.
Wall Street analysts have given Can-Fite BioPharma a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Can-Fite BioPharma wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:CANF stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Can Fite BioPharma stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Can Fite BioPharma stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “AMEX:CANF stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some AMEX:CANF stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:CANF is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Can Fite BioPharma stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Can-Fite BioPharma is scheduled to release its next quarterly earnings announcement on Friday, March 26th 2021.
View our earnings forecast for Can-Fite BioPharma.
Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) released its earnings results on Monday, November, 30th. The biotechnology company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.01. The biotechnology company earned $0.21 million during the quarter, compared to the consensus estimate of $0.50 million. Can-Fite BioPharma had a negative net margin of 1,648.57% and a negative trailing twelve-month return on equity of 215.41%.
View Can-Fite BioPharma’s earnings history.
Can-Fite BioPharma’s stock was trading at $1.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CANF stock has increased by 48.0% and is now trading at $2.25.
1 brokerages have issued 1-year price targets for Can-Fite BioPharma’s shares. Their forecasts range from $5.00 to $5.00. On average, they expect Can-Fite BioPharma’s share price to reach $5.00 in the next twelve months. This suggests a possible upside of 122.2% from the stock’s current price.
View analysts’ price targets for Can-Fite BioPharma or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:CANF stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Can-Fite BioPharma saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 255,400 shares, a decline of 14.9% from the December 15th total of 300,000 shares. Based on an average daily volume of 448,900 shares, the days-to-cover ratio is presently 0.6 days.
View Can-Fite BioPharma’s Short Interest.
Can-Fite BioPharma’s management team includes the following people:
Prof. Pnina Fishman, Scientific Founder, CEO & Director (Age 73, Pay $379k)
Mr. Motti Farbstein, Chief Operating & Financial Officer (Age 57, Pay $210k)
Dr. Sari Fishman Ph.D., VP of Bus. Devel. (Age 49, Pay $161k)
Dr. Ilan Cohn, Co-Founder & Chairman (Age 67)
Dr. Vibeke Strand FACR, M.D., FACP, FACR (USA), Sr. Clinical Advisor
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Some companies that are related to Can-Fite BioPharma include Rockwell Medical (RMTI), PhaseBio Pharmaceuticals (PHAS), Immutep (IMMP), Aptorum Group (APM), American BriVision (Holding) (ABVC), NervGen Pharma (NGENF), Anixa Biosciences (ANIX), Rezolute (RZLTD), Entasis Therapeutics (ETTX), Rezolute (RZLT), Advaxis (ADXS), Corvus Pharmaceuticals (CRVS), Vascular Biogenics (VBLT), Oncolytics Biotech (ONCY) and Celyad Oncology (CYAD).
View all of CANF’s competitors.
Based on aggregate information from Reportlab, some companies that other Can-Fite BioPharma investors own include OPKO Health (OPK), Advanced Micro Devices (AMD), BioLineRx (BLRX), Genocea Biosciences (GNCA), Arbutus Biopharma (ABUS), Biocept (BIOC), Pfizer (PFE), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI) and Palatin Technologies (PTN).
Can-Fite BioPharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “CANF.”
Shares of CANF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
One share of CANF stock can currently be purchased for approximately $2.25.
Can-Fite BioPharma has a market capitalization of $34.78 million and generates $2.03 million in revenue each year. The biotechnology company earns $-9,590,000.00 in net income (profit) each year or ($3.30) on an earnings per share basis.
Can-Fite BioPharma employs 8 workers across the globe.
The official website for Can-Fite BioPharma is www.canfite.co.il.
Can-Fite BioPharma is headquartered at 10 Bareket Street, Kiryat Matalon P.O. Box 7537, PETAH TIKVA, 49170, Israel.
Can-Fite BioPharma’s mailing address is 10 Bareket Street, Kiryat Matalon P.O. Box 7537, PETAH TIKVA, 49170, Israel. The biotechnology company can be reached via phone at +972-3-9241114 or via email at info@canfite.co.il
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How can you buy Can Fite BioPharma stock on the internet?
You can easily buy Can Fite BioPharma stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Another option is using a regulated broker like IC Markets or Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:CANF stocks in a safe and complete environment to trade in.
Where to buy Can Fite BioPharma stock?
You will first want to find a licensed broker that supports AMEX:CANF stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:CANF stocks in a safe and complete environment.
Is AMEX:CANF stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:CANF stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Can Fite BioPharma stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:CANF is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Can Fite BioPharma stock.
How do you trade Can Fite BioPharma stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Can Fite BioPharma stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:CANF stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Can Fite BioPharma stock?
To sell your AMEX:CANF stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Can Fite BioPharma stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:CANF stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
